Manga metabólica
•
0 recomendaciones•731 vistas
![Background ,[object Object],OBESIDAD: Ono T, Guthold R, Strong K, WHO Global Comparable Estimates, 2005 DIABETES: IDF Diabetes Atlas, 4th ed.International Diabetes Federation, 2009](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recomendados
Recomendados
Más contenido relacionado
La actualidad más candente
La actualidad más candente (20)
Destacado
Destacado (14)
Similar a Manga metabólica
Similar a Manga metabólica (20)
Más de Congreso Internacional Cirugía Bariátrica y Metabólica
Más de Congreso Internacional Cirugía Bariátrica y Metabólica (20)
Último
Último (20)
Manga metabólica
- 1. Efecto metabólico de la manga gástrica Camilo Boza MD FACS Assitant Professor of Surgery Pontificia Universidad Católica de Chile
- 3. clinicaltrials.gov Bariatric surgery for the treatment of Diabetes
- 5. Co-morbid conditions after Gastric Bypass BMI >35 n:1500 Preoperative (%) 1 year (Res/Imp) 5 year (Res/Imp) Hypertension 35.8 60/32 60/30 T2 Diabetes 11.5 76/20 80/20 Insulin resistance 60.4 88/11 100/0 Dyslipidemia 55 87/12 93/7
- 6. Restrictives techniques Weight loss Weight loss Hormonal effect AGB Sleeve
- 7. Wilcoxon Sign-Rank Test—Geometric mean (interquartile range). Dixon et al. Diabetes Care . 2002;25:358-363 .
- 8. Resolution of Diabetes Metanalysis n: 22.400 Total LAGB GBP BPD/DS % Resolved 82.1 55.3 80.5 99.4 % Resolved or Improved 100.0 – 100.0 – % Improved 20.4 – 20.4 – % Unchanged 0.3 – 0.0 0.7 Insulin (pml/L) -98.0 -99.6 -40.2 -125.0 HbA1c (%) -2.1 -1.4 -2.2 – Glucose (mmol/L) -4.4 -2.5 -3.9 -5.4
- 9. Boza et al, Surgical endoscopy 2009
- 10. Boza et al, Surgical endoscopy 2009
- 11. Sleeve gastrectomy Restriction Fast gastric emptying Rise in gut hormones Role of Ghrelin
- 12. % Diabetes Resolution Vidal, Lacy , Obesity Surgery 2007 BMI:49
- 13. % Diabetes Resolution Sleeve gastrectomy versus Bypass Boza et al, ASMBS 2010
- 14. Sleeve gastrectomy versus Bypass Boza et al, ASMBS 2010 Bypass Sleeve Pre Res Imp Pre Res Imp Chol ≥ 200 mg/dL 44,2 71,2 0,0 41,9 47,1 0,0 Trygl ≥ 150 mg/dL 40,7 71,4 0,0 42,0 65,7 0,0 IR 47,3 93,5 5,5 33,6 81,0 16,2 Arterial Hyp 26,8 58,2 22,3 23,5 57,5 34,8 T2DM 5,5 86,6 6,6 3,9 90,9 9,1
- 15. Diabetes Resolution Basso, Surg Endosc 2009
- 16. % Diabetes Resolution Basso, Surgical endoscopy 2009
- 17. % Diabetes Resolution Shaa, SOARD 2009 36 months after surgery
- 18. % Sleeve Gastrectomy and Diabetes Shaa, SOARD 2009 36 months after surgery
- 19. % Sleeve Gastrectomy and Diabetes Shaa, SOARD 2009 36 months after surgery
- 20. Why ?
- 21. % Melissas Vaciamiento Melissas, Obesity Surgery 2007 T1/2 Gastric Emptying
- 22. PYY after Sleeve and Bypass Valderas, 2009 SOARD 2009 Bypass Sleeve Med Treat
- 23. Glp1 Melissas Vaciamiento Peterli, Annals of Surgery 2007 Bypass Sleeve
- 24. GLP1 after Sleeve and Bypass Valderas, Boza 2010 Bypass Sleeve Med Treat
- 25. AUC for GLP1 after Sleeve and Bypass Valderas, Boza 2010
- 26. Sleeve gastrectomy as a Metabolic Surgery Camilo Boza MD FACS Assitant Professor of Surgery Pontificia Universidad Católica de Chile
- 27. Guess the BMI BMI 42. No metabolic Syndrome
- 28. Guess the BMI BMI 30. Metabolic Syndrome and Diabetes
- 29. Sleeve gastrectomy for the treatment of T2DM in patients with BMI 30-35 n:12 Age (years) 47,4 (21-59) Male Gender (%) 9 (75%) BMI (kg/m2) 33,7 (32,1-34,6) Glucosa (mg/dl) 137 (83-187) Years of Diabetes 2,5 (1-7) HA1C (%) 7,3 (6,3-8,9)
- 30. Sleeve gastrectomy for Diabetes in BMI 30-35 n:12 Preop 1 año Postop ∆ p BMI (kg/m 2 ) 33,7 (32,1-34,6) 27,5 (21,8-30) - 6,2 0,01 Medication % 75 17 - 58 --- Glucosa (mg/dl) 137 (83-187) 93,5 (80-172) - 43,5 0,01 Hb A1c (%) 7,3 (6,3-8,9) 5,8 (4,9-6,9) - 2,4 0,06 Homa - IR 6,46 (1,6-14,2) 1,8 (1,7-6,5) - 4,7 0,06 Insulin 25,4 (9,3-45) 9,9(6,7-16,9) -15,5 0,04
- 31. 12 Month Diabetes resolution Resolution (HbA1c normal sin medicación) 70% Better control 13,3 % No change 16,7%
- 32. BMI evolution for Sleeve 30-35
- 33. Bypass versus Sleeve for Diabetes BMI 25-35 BMI 25-35 Lee, 2012